Stockreport

Lumos Pharma to Participate in H.C. Wainwright 26th Annual Global Investment Conference

Lumos Pharma, Inc.  (LUMO) 
PDF AUSTIN, Texas, Aug. 15, 2024 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a clinical-stage biopharmaceutical company focused on therapeutics for rare diseases [Read more]